MMPI
PRNB

Morgenthaler Management Partners IX’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Morgenthaler Management Partners IX’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,195,125
Closed -$60.1M – 3
2018
Q4 		$60.1M Buy
+2,195,125
New +$56.6M 48.03% 1

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgenthaler Management Partners IX's PRNB Position: Q1 2019 in Review

Morgenthaler Management Partners IX sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q1 2019, closing a stake of 2,195,125 shares — an estimated $60.1M sold.

Morgenthaler Management Partners IX first reported a position in PRNB in Q4 2018 and held it in 1 quarter. The position peaked at $60.1M in Q4 2018. 62 funds tracked by Wall St. Rank hold PRNB as of Q1 2019.

  • Morgenthaler Management Partners IX reported no remaining Principia Biopharma Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Morgenthaler Management Partners IX sold 2,195,125 Principia Biopharma Inc. Common Stock shares in Q1 2019, an estimated $60.1M.
  • Morgenthaler Management Partners IX first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Morgenthaler Management Partners IX's Principia Biopharma Inc. Common Stock position peaked at $60.1M in Q4 2018.
  • 62 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q1 2019.

Based on Morgenthaler Management Partners IX's 13F filing for Q1 2019, filed 15 May 2019.